Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly GLP1 2.4 mg in type 2 diabetes: A multicentre, randomised, double-blind, active-controlled, phase 2 trial
No significant pharmacokinetic interaction observed between cagrilintide and semaglutide 1-3
Get step-by-step protocols for reconstitution, injection technique, and dosing specific to your condition
Capsules and shots may involve different dosing, absorption, monitoring needs, and safety considerations
Tributyrin is a triglyceride form of butyric acid that the company describes as a more targeted delivery mechanism for butyrate than sodium butyrate, which is known for its odor and may be partially absorbed before reaching the colon